Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer

被引：0
|
作者：
Sung-chan Gwark
Han Shin Lee
Youngjoo Lee
Sae Byul Lee
Guiyun Sohn
Jisun Kim
Il Yong Chung
Beom Seok Ko
Hee Jeong Kim
Byung Ho Son
Jin-Hee Ahn
Kyung Hae Jung
Sung-Bae Kim
Hee Jin Lee
Gyung-Yub Gong
Sei Hyun Ahn
Jong Won Lee
机构：
[1] University of Ulsan College of Medicine,Department of Surgery
[2] Asan Medical Center,Department of Oncology
[3] University of Ulsan College of Medicine,Department of Pathology
[4] Asan Medical Center,undefined
[5] University of Ulsan College of Medicine,undefined
[6] Asan Medical Center,undefined
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2166 / 2174
页数：8
相关论文
共 50 条
  • [1] Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer
    Gwark, Sung-chan
    Lee, Han Shin
    Lee, Youngjoo
    Lee, Sae Byul
    Sohn, Guiyun
    Kim, Jisun
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Son, Byung Ho
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Sung-Bae
    Lee, Hee Jin
    Gong, Gyung-Yub
    Ahn, Sei Hyun
    Lee, Jong Won
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (07) : 2166 - 2174
  • [2] Clinical implication of HER2/neu status in hormone receptor positive pure mucinous breast cancer
    Gwark, S-C
    Lee, J. W.
    Lee, S. B.
    Sohn, G.
    Kim, J.
    Chung, I. Y.
    Ko, B. S.
    Kim, H. J.
    Son, B. H.
    Ahn, S. H.
    CANCER RESEARCH, 2019, 79 (04)
  • [3] The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
    Zhao, Hengqiang
    Gong, Yiping
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] HER2 and hormone receptor-positive breast cancer—blocking the right target
    Javier Cortés
    Cristina Saura
    Meritxell Bellet
    Eva Muñoz-Couselo
    Natalia Ramírez-Merino
    Virginia Calvo
    Jose Pérez
    María Vidal
    Nature Reviews Clinical Oncology, 2011, 8 : 307 - 311
  • [5] HER2 and hormone receptor-positive breast cancer-blocking the right target
    Cortes, Javier
    Saura, Cristina
    Bellet, Meritxell
    Munoz-Couselo, Eva
    Ramirez-Merino, Natalia
    Calvo, Virginia
    Perez, Jose
    Vidal, Maria
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (05) : 307 - 311
  • [6] Increased HER2/neu expression in recurrent hormone receptor-positive breast cancer
    Kaklamani, Virginia G.
    Cianfrocca, Mary
    Ciccone, Jennifer
    Kindy, Kelly
    Rademaker, Alfred
    Wiley, Elizabeth L.
    Gradishar, William
    O'Regan, Ruth M.
    BIOMARKERS, 2010, 15 (02) : 191 - 193
  • [7] Clinical trial data and emerging immunotherapeutic strategies: hormone receptor-positive, HER2− negative breast cancer
    Matthew R. Kearney
    Julia E. McGuinness
    Kevin Kalinsky
    Breast Cancer Research and Treatment, 2021, 189 : 1 - 13
  • [8] Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen
    Yong Wha Moon
    Seho Park
    Joo Hyuk Sohn
    Dae Ryong Kang
    Ja Seung Koo
    Hyung Seok Park
    Hyun Cheol Chung
    Byeong-Woo Park
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1123 - 1130
  • [9] Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen
    Moon, Yong Wha
    Park, Seho
    Sohn, Joo Hyuk
    Kang, Dae Ryong
    Koo, Ja Seung
    Park, Hyung Seok
    Chung, Hyun Cheol
    Park, Byeong-Woo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (07) : 1123 - 1130
  • [10] Baseline serum extracellular domain HER2 expression in hormone receptor-positive metastatic breast cancer: correlation with known tissue HER2 status
    Johnston, S.
    O'Rouke, L.
    Wang, W.
    Pegram, M.
    Press, M. F.
    Maltzman, J.
    CANCER RESEARCH, 2009, 69 (02) : 246S - 247S
12345